Different bone sites-specific response to diabetes rat models: Bone density, histology and microarchitecture.

BACKGROUND AND PURPOSE:Diabetes mellitus (DM) is the most common metabolic disorder that is characterized by hyperglycemia, it can be categorized by T1DM and T2DM. T1DM is also reported to cause bone loss. However, most reports regarding this aspect of T1DM have only investigated a single site; a co...

Full description

Bibliographic Details
Main Authors: Yunwei Hua, Ruiye Bi, Yue Zhang, Luchen Xu, Jiaoyang Guo, Yunfeng Li
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2018-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC6197850?pdf=render
_version_ 1818027190526148608
author Yunwei Hua
Ruiye Bi
Yue Zhang
Luchen Xu
Jiaoyang Guo
Yunfeng Li
author_facet Yunwei Hua
Ruiye Bi
Yue Zhang
Luchen Xu
Jiaoyang Guo
Yunfeng Li
author_sort Yunwei Hua
collection DOAJ
description BACKGROUND AND PURPOSE:Diabetes mellitus (DM) is the most common metabolic disorder that is characterized by hyperglycemia, it can be categorized by T1DM and T2DM. T1DM is also reported to cause bone loss. However, most reports regarding this aspect of T1DM have only investigated a single site; a comparison of bone loss from different areas of the body is still lacking. METHODS:Thirty-five 12-week-old Sprague Dawley® (SD) rats were separated to seven groups. Five rats were euthanized without any surgery at 0 weeks for histological examination and determination of baseline characteristics. In 15 of the rats, DM was induced via Streptozotocin (STZ)-injection, and they were separated to 3 groups (4 weeks, 8 weeks and 12 weeks after STZ-injection). The remaining 15 rats were used as the control group (4 weeks, 8 weeks and 12 weeks after saline-injection). We tested bone-mass loss at four skeletal sites, the tibia, the femur greater trochanter, the spine, and the mandibular bones using micro-computed tomography (CT) and histological tests. RESULTS:Tibia was influenced the most obvious(BV/TV decreased by 27.3%, 52.5%, and 81.2% at 4 weeks, 8 weeks, and 12 weeks, respectively. p<0.05). In contrast, the other three sites were influenced to a lesser extent and bone loss became prominent at a later time point according to the histological and micro-CT tests(Femur: BV/TV did not decrease significantly at the first month or second month. However, and decreased by 49.4% at the third month, P<0.05. Mandible: the BV/TV only decreased by 6.5% at 1 month after STZ-injection. There was still a significant difference between the second and third months. The BV/TV decreased by 47.0% and 68.1% at 2 months and 3 months, respectively, (p<0.05) Spine: the BV/TV only decreased by 6.7%. However, significant change was observed in the spine at the second month and third month after STZ injection. The BV/TV decreased by 45.4% and 64.3%, respectively, p<0.05). CONCLUSION:The results indicate that T1DM can severely influence the bone structure of the 4 skeletal sites. Further, areas with dense trabecular bones were influenced less and at a later time point in comparison to the tibial region. CLINICAL RELEVANCE:Our research can serve as a guide to help increase the success rate of implant treatment, and help decrease the fracture risk in different bone types with greater accuracy.
first_indexed 2024-12-10T04:43:58Z
format Article
id doaj.art-2c4f91a48df64a23b1e1e0ece2626552
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-12-10T04:43:58Z
publishDate 2018-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-2c4f91a48df64a23b1e1e0ece26265522022-12-22T02:01:47ZengPublic Library of Science (PLoS)PLoS ONE1932-62032018-01-011310e020550310.1371/journal.pone.0205503Different bone sites-specific response to diabetes rat models: Bone density, histology and microarchitecture.Yunwei HuaRuiye BiYue ZhangLuchen XuJiaoyang GuoYunfeng LiBACKGROUND AND PURPOSE:Diabetes mellitus (DM) is the most common metabolic disorder that is characterized by hyperglycemia, it can be categorized by T1DM and T2DM. T1DM is also reported to cause bone loss. However, most reports regarding this aspect of T1DM have only investigated a single site; a comparison of bone loss from different areas of the body is still lacking. METHODS:Thirty-five 12-week-old Sprague Dawley® (SD) rats were separated to seven groups. Five rats were euthanized without any surgery at 0 weeks for histological examination and determination of baseline characteristics. In 15 of the rats, DM was induced via Streptozotocin (STZ)-injection, and they were separated to 3 groups (4 weeks, 8 weeks and 12 weeks after STZ-injection). The remaining 15 rats were used as the control group (4 weeks, 8 weeks and 12 weeks after saline-injection). We tested bone-mass loss at four skeletal sites, the tibia, the femur greater trochanter, the spine, and the mandibular bones using micro-computed tomography (CT) and histological tests. RESULTS:Tibia was influenced the most obvious(BV/TV decreased by 27.3%, 52.5%, and 81.2% at 4 weeks, 8 weeks, and 12 weeks, respectively. p<0.05). In contrast, the other three sites were influenced to a lesser extent and bone loss became prominent at a later time point according to the histological and micro-CT tests(Femur: BV/TV did not decrease significantly at the first month or second month. However, and decreased by 49.4% at the third month, P<0.05. Mandible: the BV/TV only decreased by 6.5% at 1 month after STZ-injection. There was still a significant difference between the second and third months. The BV/TV decreased by 47.0% and 68.1% at 2 months and 3 months, respectively, (p<0.05) Spine: the BV/TV only decreased by 6.7%. However, significant change was observed in the spine at the second month and third month after STZ injection. The BV/TV decreased by 45.4% and 64.3%, respectively, p<0.05). CONCLUSION:The results indicate that T1DM can severely influence the bone structure of the 4 skeletal sites. Further, areas with dense trabecular bones were influenced less and at a later time point in comparison to the tibial region. CLINICAL RELEVANCE:Our research can serve as a guide to help increase the success rate of implant treatment, and help decrease the fracture risk in different bone types with greater accuracy.http://europepmc.org/articles/PMC6197850?pdf=render
spellingShingle Yunwei Hua
Ruiye Bi
Yue Zhang
Luchen Xu
Jiaoyang Guo
Yunfeng Li
Different bone sites-specific response to diabetes rat models: Bone density, histology and microarchitecture.
PLoS ONE
title Different bone sites-specific response to diabetes rat models: Bone density, histology and microarchitecture.
title_full Different bone sites-specific response to diabetes rat models: Bone density, histology and microarchitecture.
title_fullStr Different bone sites-specific response to diabetes rat models: Bone density, histology and microarchitecture.
title_full_unstemmed Different bone sites-specific response to diabetes rat models: Bone density, histology and microarchitecture.
title_short Different bone sites-specific response to diabetes rat models: Bone density, histology and microarchitecture.
title_sort different bone sites specific response to diabetes rat models bone density histology and microarchitecture
url http://europepmc.org/articles/PMC6197850?pdf=render
work_keys_str_mv AT yunweihua differentbonesitesspecificresponsetodiabetesratmodelsbonedensityhistologyandmicroarchitecture
AT ruiyebi differentbonesitesspecificresponsetodiabetesratmodelsbonedensityhistologyandmicroarchitecture
AT yuezhang differentbonesitesspecificresponsetodiabetesratmodelsbonedensityhistologyandmicroarchitecture
AT luchenxu differentbonesitesspecificresponsetodiabetesratmodelsbonedensityhistologyandmicroarchitecture
AT jiaoyangguo differentbonesitesspecificresponsetodiabetesratmodelsbonedensityhistologyandmicroarchitecture
AT yunfengli differentbonesitesspecificresponsetodiabetesratmodelsbonedensityhistologyandmicroarchitecture